Workshops

Objective/Description

• This Symposium will provide a forum for in-depth reviews of the current status of lung cancer screening, focusing on the forefront issues concerning the implementation of lung cancer screening in 2019, with internationally recognized experts, in a highly interactive setting.
• This CT Symposium is designed to provide the IASLC Membership with an opportunity to discuss practical issues involved in the lung cancer screening implementation, with Experts in the field.

Objective/Description
Genomic medicine is revolutionizing patient care. Of all specialties, oncology has been most affected as next-generation sequencing of tumor specimens to find drug-targetable mutations has entered clinical practice. Treatment of lung cancer has been especially impacted by this new testing paradigm. As such, oncologists must be conversant with the fundamental aspects of clinical genomics. Using a case-based, interactive, small-group approach, faculty will review introductory principles related to genomic assays, interpretation of results and application to patient care. The workshop will also include practical hands-on instruction with the use of online genomic pathology tools. As such, participants should bring a tablet or laptop (preferred) if available to facilitate participation in this aspect of the course.

Each exercise consists of:

• An instructor-delivered 15-30 minute PowerPoint lecture to relay content needed to undertake the team-based learning (TBL) activity.
• A 45-60-minute activity consisting of teams of 3-6 participants working together to answer a series of clinically relevant questions including some necessitating the use of online genomic tools.
• An instructor-delivered 15-30 minute PowerPoint lecture presenting answers to the questions and incorporating a discussion of team responses.

Facilitators/Speakers:

• Ramaswamy Govindan MD: Director, Section of Medical Oncology, Washington University School of Medicine
• Richard L. Haspel, MD, PhD, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA
• Siddhartha Devarakonda, MD, Washington University School of Medicine, St. Louis, MO, USA
• Pedro L. Fernandez Ruiz, MD, PhD, Hospital Germans Trias i Pujol, Badalona, and Universidad Autonoma de Barcelona, Spain

Objective/Description
To update on all aspects of MPM diagnosis and treatment.

Objective/Description
To learn the basic as well as the tips and tricks of thoracic ultrasonography procedures in the diagnosis and staging of lung cancer

A real hands-on multi station workshop where attendees will have the opportunity to practice individually and learn from internationally well-known faculty. Groups of maximum 4 people will cover 6 stations during the 90’ session. Three stations will be dedicated to lineal EBUS for staging the mediastinum (one in a Symbionix Simulator, the second one showing the different needles available in the market, and another practicing in a plastic model), radial EBUS in a plastic model and finally thoracic ultrasound to understand the anatomy and the last one dedicated to pleural drainage.

Agenda:
08:00 – 08:15 - Welcome and Introduction, Antoni Rosell, Spain

08:15 – 11:30 - Hands-On Session on 6 Stations:
-Lineal EBUS | Kazuhiro Yusufuku, Canada
-EBUS Needles | Tim Murgu, USA
-Lineal EBUS Simulator | Marta Diez-Ferrer, Spain
-Radial EBUS | Christophe Dooms, Belgium
-Transthoracic Ultrasound | Rachid Tazi, Spain
-Chest Tube Drainages | Najib Rahman, UK

11:30 – 12:30 - Break

12:30 – 16:00 - Hands-On Session on 6 Stations
-Lineal EBUS | Kazuhiro Yusufuku, Canada
-EBUS Needles | Tim Murgu, USA
-Lineal EBUS Simulator | Marta Diez-Ferrer, Spain
-Radial EBUS | Christophe Dooms, Belgium
-Transthoracic Ultrasound | Rachid Tazi, Spain
-Chest Tube Drainages | Najib Rahman, UK

Objective/Description
Provide an overview on how patient treatment decisions can be made with clinical decision support around information from biomarker testing scenarios.

Agenda

07:30 – 08:00 - Arrival and Breakfast

08:00 – 08:10 - Welcome and Opening Remarks, Noemi Reguart, Hospital Clínic Barcelona, Spain

08:10 – 08:35 - New Approaches in Lung Cancer: Biomarker Applications in Helping the Diagnosis and Early Diagnosis, Rafael Molina, Hospital Clinic Barcelona, Spain

08:35 – 09:00 - RTD – IHC Assessments for Targeted Therapy – Focus on ALK and ROS1 and Use of ROS1 IHC – Talk Followed by Question Time,  Frédérique Penault-Llorca, Centre Jean Perrin, France

09:00 – 09:25 - The Challenges and Opportunities of Molecular Diagnostic Tools – Towards a Personalized Lung Cancer Healthcare, Noemi Reguart, Hospital Clínic Barcelona, Spain

09:25 – 09:40 - Break

09:40 – 10:05 - How to Improve Cancer MDT Effectiveness by Use of Diagnostic Algorithms, Tuk-Kay Locke, Tunbridge Wells Hopsital, United Kingdom

10:05 – 11:25 - Clinical Case Reviews in a Multidisciplinary Setting

11:25 – 11:30 - Closing Remarks, Noemi Reguart, Hospital Clínic Barcelona, Spain

Objective/Description
Sharing good practice for thoracic Nurse Specialist and AHP with specific interest in lung cancer

Objective/Description

• Introduction
• Dr. Gazdar’s Legacy in Cancer Research
• The Impact of Cell Line Development in Lung Cancer Research
• Dr. Gazdar as a Mentor
• The Importance of Elucidating Genomic Events Is Lung Premalignancy
• New Developments in Sclc and Neuroendocrine Tumors
• Dr. Gazdar as a Friend and Final Remarks